Etilevodopa
Etilevodopa.svg
Ball-and-stick model of the etilevodopa molecule
Clinical data
ATC code
Identifiers
  • ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.223.003 Edit this at Wikidata
Chemical and physical data
FormulaC11H15NO4
Molar mass225.244 g·mol−1
3D model (JSmol)
  • O=C(OCC)[C@@H](N)Cc1cc(O)c(O)cc1
  • InChI=1S/C11H15NO4/c1-2-16-11(15)8(12)5-7-3-4-9(13)10(14)6-7/h3-4,6,8,13-14H,2,5,12H2,1H3/t8-/m0/s1 checkY
  • Key:NULMGOSOSZBEQL-QMMMGPOBSA-N checkY
  (verify)

Etilevodopa (TV-1203) is a dopaminergic agent which was developed as a treatment for Parkinson's disease.[1] It is the ethyl ester of levodopa. It was never marketed.

See also

References

  1. ^ Djaldetti R, Giladi N, Hassin-Baer S, Shabtai H, Melamed E (November–December 2003). "Pharmacokinetics of etilevodopa compared to levodopa in patients with Parkinson's disease: an open-label, randomized, crossover study". Clinical Neuropharmacology. 26 (6): 322–6. doi:10.1097/00002826-200311000-00012. PMID 14646613. S2CID 23992241.